← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2011Last known activity
Mar 8, 2023
Timeline
2000s
- Jun 1, 2004
Beijing Minhai Biotechnology Co., Ltd— Founded
Drugs by trial phase (14 distinct, 17 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (13 own, 0 via acquisition)
- 23-valent pneumococcal polysaccharide vaccine
- rabies vaccine (purified chick embryo cell vaccine)
- mpv-a
- mpv-acyw135
- pneumococcal 7-valent conjugate vaccine
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- haemophilus influenzae type b conjugate vaccine
- bivalent oral polio vaccine (bopv), type 1 and type 3
- quadrivalent groups a, c, y, and w-135 meningococcal vaccine
- inactivated SARS-Cov-2 vaccine
- inactivated sabin strain polio virus
- Bivalent group A and C meningococcal vaccine
- Inactivated polio virus - Enhanced
Indications
Recent trials (17)
- NCT06752174Lead sponsorPhase 3Mar 8, 2023
- NCT05003466CollaboratorPhase 2Sep 30, 2021
- NCT05003479CollaboratorPhase 1Aug 31, 2021
- NCT04852705CollaboratorPhase 3May 31, 2021
- NCT04756323Lead sponsorPhase 2Oct 27, 2020
- NCT04758273Lead sponsorPhase 1Oct 7, 2020
- NCT06210737Lead sponsorPhase 4Sep 26, 2019
- NCT03902054CollaboratorPhase 2Dec 28, 2017
- NCT07297186Lead sponsorPhase 3Aug 21, 2017
- NCT04264598CollaboratorPhase 1Aug 21, 2017
- NCT02494999CollaboratorPhase 3Jun 1, 2016
- NCT02288286CollaboratorPhase 3Nov 1, 2014
- NCT02281396CollaboratorPhase 1Nov 1, 2014
- NCT02560272Lead sponsorPhase 3Sep 1, 2014
- NCT02003313Lead sponsorPhase 3Nov 1, 2013
Details
- Founded
- Beijing, CN Jun 1, 2004
- Last known activity
- Mar 8, 2023